We have previously reported that administration of Bovril to women and children is commonly followed by a rise in serum growth hormone (HGH), and have suggested that Bovril stimulation provides a safe method for investigating children with suspected growth hormone deficiency (Jackson, Grant, and Clayton, 1968) . This paper describes the results of Bovril tests in a further 60 abnormally small children with a variety of disorders and compares them with the serum HGH results obtained in the same subjects after intravenous injection of insulin.
Subjects and Methods Subjects. 40 boys and 20 girls between the ages of 3 and 181 years were studied. The heights of all the subjects were below the 3rd centile for age (Tanner, Whitehouse, and Takaishi, 1966) . In 22 cases, short stature was associated with recognized clinical conditions (Table) . The remaining 38 children, many of whom could not be classified with certainty, had growth rates between 1 -3 and 6-7 cm./year, showed up to 7 years' delay in bone maturation at the wrist and hand (Tanner, Whitehouse, and Healy, 1962) , and had normal plasma levels of protein-bound iodine.
Methods. Bovril and insulin tests were carried out after an overnight fast, with the subjects resting on their beds. All the tests began between 9.30 and Received 26 January 1970. children with suspected growth hormone the advantages of being safe and avoiding Other statistical parameters of the method showed no change from those previously described (Jackson et al., 1968) .
Some of the patients had been treated with HGH several months before the Bovril and insulin tests. Serum specimens from these patients gave negative results when tested for anti-HGH antibodies, using electrophoresis in acrylamide gel to separate free and bound 125I HGH (Fitschen, 1964) . Recovery of HGH from these specimens, and results obtained when they were assayed at several dilutions, also indicated that previous treatment with HGH did not interfere with the immunoassay results in these subjects.
Previous studies have indicated that hypopituitary subjects have peak serum HGH levels of less than 10 tsIU/ml. after Bovril (Jackson et al., 1968) . Accordingly, a serum HGH level over 10 ,uIU/ml., which is roughly equivalent to 5 mpsg. Wilhelmi-type HGH/ml., has been taken as a normal response to Bovril or insulin.
Blood glucose was estimated on samples from the insulin tests, using a glucose-oxidase method adapted for the autoanalyser (Trinder, 1969) . A fall in blood glucose of more than 50% after insulin was considered a satisfactory stimulus for growth hormone release.
Results
The peak serum (Fig.) . Though the results for the two tests showed good correlation in these subjects, the serum HGH values after insulin were generally higher than those obtained after Bovril.
In 18 patients the serum HGH levels were less than 10 ,LIU/ml. throughout both tests. 8 of these subjects had a history of surgery for craniopharyngioma and a further 3 had shown obvious acceleration of growth during earlier treatment with HGH. Isolated HGH deficiency was considered a likely diagnosis in a further 6 patients who had growth rates between 2 3 cm./year and 4 6 cm./year, with considerable delay in bone maturation. One patient who failed to respond to Bovril and insulin had Turner's syndrome (XX/XO mosaic) with a normal bone age, and was almost certainly not growth hormone deficient.
The one patient in whom there was an obvious discrepancy between the results of the two tests was a girl with features of the emotional deprivation syndrome. She failed to respond to Bovril 2 days after admission to hospital but had a peak HGH level of 23 9 ,LIU/ml. during an insulin test 4 days later. However, a serum HGH level of 23-7 1IU/ ml. was obtained during a second Bovril test performed 3 weeks after admission.
Minor discrepancies, within the limits of experimental error, were found between the results of the paired tests in 4 subjects. Two boys with growth rates of 2-8 cm./year and 3 *6 cm./year, and 3 -2 and 4 8 years' delay in bone maturation had serum HGH levels of less than 10 ptIU/ml. after insulin but values of 10 * 8 ,LIU/ml. and 13 * 4 [LIU/ml. after Bovril. One boy who was growing at a rate of 5 9 cm./year had peak HGH values of 12 0 ,uIU/ ml. after insulin and 9-6 [LIU/ml. after Bovril, and another boy with a growth rate of 5 -1 cm./year had peak HGH levels of 13-1 tLIU/ml. after insulin and 5-9 [LIU/ml. after Bovril. Discussion Several tests for assessing patients with suspected HGH deficiency have been described. Insulininduced hypoglycaemia (Roth et al., 1963) , and 0 545 a group.bmj.com on June 20, 2017 -Published by http://adc.bmj.com/ Downloaded from arginine infusion (Knopf et al., 1965) are probably the two most commonly used procedures, but injection of pyrogen (Frohman, Aceto, and MacGillivary, 1967) , vasopressin (Gagliardino, Bailey, and Martin, 1967) , glucagon (Mitchell, Byrne, and Silver, 1969) or tolbutamide (Hunter and Greenwood, 1964) , and administration of glucose by mouth (Hunter et al., 1967) have all been advocated as suitable test procedures. The above results, together with our earlier findings in 63 children (Jackson et al., 1968) , indicate that the Bovril test is of value in the investigation of children with possible HGH deficiency, and that it compares favourably with the more commonly used insulin test. In particular, it is safe and avoids intravenous administration.
Though many of our subjects showed a conspicuous rise in serum HGH during both stimulation tests, a few had borderline responses, and the results could not be interpreted with certainty. Similar difficulties have been encountered by other workers, and it has been suggested that these blunted responses may indicate partial HGH deficiency (Youlton, Kaplan, and Grumbach, 1969) . Repeat studies in our patients, together with assessment of their response to HGH therapy, may provide further evidence for this concept.
Several workers have reported discrepancies between the results of arginine and insulin stimulation tests (Parker, Hammond, and Daughaday, 1967; Raiti, Davis, and Blizzard, 1967; Youlton et al., 1969) . Only one subject in the present study showed very discrepant responses to Bovril and insulin. It is possible that the patient with Turner's syndrome in the present series who failed to respond to either test might have shown a normal HGH response to another stimulus, such as arginine infusion.
Capillary blood samples were used in the Bovril tests described above, and it is possible that the stress of repeated finger-pricks, together with the diurnal changes in serum HGH which are common in children (Hunter and Rigal, 1966; Frohman et al., 1967) , may have contributed to a rise in HGH during some of the tests. We have not carried out a systematic study in children to investigate this possibility but limited studies in a small number of children, together with results obtained in women (Jackson et al., 1968; Buckler, 1969) 
